Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment

Authors not listed

Centre Hospitalier de Saint-Denis · 2022

Abstract

This study aims to better understand Alzheimer's disease by looking at brain scans, specifically MRI images, to detect early signs of brain changes linked to the disease. Researchers are focusing on the hippocampus, a part of the brain that shrinks in people with Alzheimer's. The study will also explore other brain changes that often happen alongside hippocampal shrinkage. By analyzing these brain images, the study hopes to find ways to diagnose Alzheimer's earlier and more accurately using advanced imaging techniques.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-01 MST

Cite this

APA
Anonymous. (2022). Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment. <em>Centre Hospitalier de Saint-Denis</em>. https://clinicaltrials.gov/study/NCT06965816
Vancouver
Anonymous. Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment. Centre Hospitalier de Saint-Denis. 2022.
BibTeX
@misc{anon2022UsingN, title = {Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment}, author = {Anonymous}, journal = {Centre Hospitalier de Saint-Denis}, year = {2022}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings